碳纳米示踪剂联合达芬奇机器人治疗食管癌的疗效及预后分析

Efficacy and prognostic analysis of carbon nanotracers combined with the da Vinci robot in the treatment of esophageal cancer.

作者信息

Qi Fen-Qiang, Sun Yan

机构信息

Cardiothoracic Surgery, The fourth affiliated hospital of Guangxi medical university/Liuzhou workers hospital, Liuzhou 545005, Guangxi Zhuang Autonomous Region, China.

出版信息

World J Clin Cases. 2024 Aug 6;12(22):4924-4931. doi: 10.12998/wjcc.v12.i22.4924.

Abstract

BACKGROUND

Traditional methods cannot clearly visualize esophageal cancer (EC) tumor contours and metastases, which limits the clinical application of da Vinci robot-assisted surgery.

AIM

To investigate the efficacy of the da Vinci robot in combination with nanocarbon lymph node tracers in radical surgery of EC.

METHODS

In total, 104 patients with early-stage EC who were admitted to Liuzhou worker's Hospital from January 2020 to June 2023 were enrolled. The patients were assigned to an observation group ( = 52), which underwent da Vinci robot-assisted minimally invasive esophagectomy (RAMIE) with the intraoperative use of nanocarbon tracers, and a control group ( = 52), which underwent traditional surgery treatment. The operation time, intraoperative blood loss, postoperative drainage tube indwelling time, hospital stay, number of lymph nodes dissected, incidence of complications, and long-term curative effects were comparatively analyzed. The postoperative stress response C-reactive protein (CRP), cortisol, epinephrine (E) and inflammatory response interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-alpha (TNF-α) were evaluated.

RESULTS

Compared with the control group, the observation group had significantly lower postoperative CRP, cortisol, and E levels ( < 0.05) with a milder inflammatory response, as indicated by lower IL-6, IL-10, and TNF-α levels ( < 0.05). Patients who underwent RAMIE had less intraoperative blood loss and shorter operation times and hospital stays than those who underwent traditional surgery. The average number of dissected lymph nodes, time of lymph node dissection, and mean smallest lymph node diameter were all significantly lower in the observation group ( < 0.05). The rate of postoperative complications was 5.77% in the observation group, significantly lower than the 15.38% observed in the control group. Furthermore, the lymphatic metastasis rate, reoperation rate, and 12- and 24-month cumulative mortality in the observation group were 1.92%, 0%, 0%, and 0%, respectively, all of which were significantly lower than those in the control group ( < 0.05).

CONCLUSION

The treatment of EC using the da Vinci robot combined with nanocarbon lymph node tracers can achieve good surgical outcomes and demonstrates promising clinical applications.

摘要

背景

传统方法无法清晰显示食管癌(EC)肿瘤轮廓及转移情况,这限制了达芬奇机器人辅助手术的临床应用。

目的

探讨达芬奇机器人联合纳米碳淋巴结示踪剂在EC根治性手术中的疗效。

方法

选取2020年1月至2023年6月在柳州市工人医院收治的104例早期EC患者。将患者分为观察组(n = 52),接受达芬奇机器人辅助微创食管切除术(RAMIE)并术中使用纳米碳示踪剂;对照组(n = 52),接受传统手术治疗。比较分析手术时间、术中出血量、术后引流管留置时间、住院时间、清扫淋巴结数量、并发症发生率及远期疗效。评估术后应激反应C反应蛋白(CRP)、皮质醇、肾上腺素(E)以及炎症反应白细胞介素(IL)-6、IL-8、IL-10和肿瘤坏死因子-α(TNF-α)。

结果

与对照组相比,观察组术后CRP、皮质醇和E水平显著降低(P < 0.05),炎症反应较轻,表现为IL-6、IL-10和TNF-α水平较低(P < 0.05)。接受RAMIE的患者术中出血量少于接受传统手术的患者,手术时间和住院时间更短。观察组清扫淋巴结的平均数量、淋巴结清扫时间及平均最小淋巴结直径均显著更低(P < 0.05)。观察组术后并发症发生率为5.77%,显著低于对照组的15.38%。此外,观察组的淋巴转移率、再次手术率以及12个月和24个月累积死亡率分别为1.92%、0%、0%和0%,均显著低于对照组(P < 0.05)。

结论

使用达芬奇机器人联合纳米碳淋巴结示踪剂治疗EC可取得良好手术效果,具有广阔的临床应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254c/11238817/fe5efccf389c/WJCC-12-4924-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索